Both pharmacological inhibition of MEK1 / 2, rapid downstream phosphorylation sites of BRAF, and stable silencing of BRAF through lentiviral transduction of shRNA prevented proliferation and stopped the formation of advanced tumor cells derived from low‐grade gliomas.39 The gene discussed is BRAF; the disease is neoplasm.